Prof. Dr. Hakan Harputluoğlu, MD
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2013J BUON«Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)»· co-author
-
2012Oncol Res Treat (Onkologie)«Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience»· co-author
-
2014J BUON«Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey»· co-author
-
2008J Neurooncol«Prognostic factors in breast cancer patients with brain metastases»· first author
-
2007Hum Pathol«Potential targeted therapy options in the management of basal cell subtype of breast carcinoma»· first author
-
2022J Clin Oncol«Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)»· co-author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.